- Home
- QNST vs CRMD Comparison
QNST vs CRMD Comparison
Compare QNST & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNST | CRMD |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 792.3M | 876.7M |
| IPO Year | 2010 | 2010 |
Fundamental Metrics
Financial Performance| Metric | QNST | CRMD |
|---|---|---|
| Price | $15.37 | $10.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $26.40 | $17.43 |
| AVG Volume (30 Days) | 549.4K | ★ 3.0M |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.18 | ★ 2.25 |
| Revenue | ★ $1,100,345,000.00 | $214,303,672.00 |
| Revenue This Year | $11.18 | $565.64 |
| Revenue Next Year | $9.54 | $46.09 |
| P/E Ratio | $85.38 | ★ $4.58 |
| Revenue Growth | 43.12 | ★ 1647.67 |
| 52 Week Low | $12.98 | $5.60 |
| 52 Week High | $25.50 | $17.43 |
Technical Indicators
Market Signals| Indicator | QNST | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 63.73 | 48.12 |
| Support Level | $13.68 | $9.20 |
| Resistance Level | $14.12 | $9.88 |
| Average True Range (ATR) | 0.48 | 0.56 |
| MACD | 0.16 | 0.00 |
| Stochastic Oscillator | 91.52 | 39.33 |
Price Performance
Historical ComparisonAbout QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia. Geographically, it operates in United States and Internationally, of which maximum revenue is derived from United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.